Immune Wellness Research and Evidence

What this page is for

Immune wellness is a field with lots of research and lots of marketing. This page shows how much has been published on a handful of topics, explains why counts do not equal effectiveness, and gives a checklist for judging a study. For the topic pages themselves, start with supporting immune health.

PubMed snapshot (retrieved 2026-10-22)

These are record counts from PubMed using the NCBI E-utilities search service. The exact query is shown so anyone can repeat it; counts change daily as new papers are added. [1]

Common cold5,135

Vitamin C and colds176

Vitamin D and respiratory infection144

Zinc and colds163

Echinacea1,546

Elderberry1,372

Garlic and immunity337

Mushrooms and immunity800

Sleep and immunity775

Influenza vaccination27,709

What the counts do and do not mean

Counts show how much has been published, not whether something works. A topic can have many records because it is popular, because it is studied in the lab or in animals, or because it is mostly opinion pieces. Records also include studies of different people, doses and products. For example, the elderberry and echinacea counts are large, but NCCIH describes only a small number of human studies of elderberry for colds, and a Cochrane review of echinacea could not pool its results because products differed so much. [2][3] Likewise, a review of 39 randomized studies of popular immune supplements concluded that gaps prevented firm statements. [4]

How the evidence changes over time

Vitamin D is a good example. A 2017 individual-participant meta-analysis found supplementation reduced risk of acute respiratory infection (odds ratio 0.88). [5] A 2025 update with 40 studies and 61,589 participants found the overall effect no longer statistically significant (odds ratio 0.94, 95% CI 0.88 to 1.00). [6] New studies can move the picture; look for the most recent systematic review.

How to judge a study about immunity or colds

1. Which outcome? Fewer infections, shorter illness and milder symptoms are meaningful. Changes in lab markers (such as immune-cell percentages) are not the same as fewer infections. A Cochrane review of reishi in cancer patients, for example, reported immune-cell changes in a different population. [7]
2. Which people? Healthy adults, children, or people with a condition? Do not transfer findings across groups. [4]
3. Which preparation? A food, a tea, an extract and a supplement are different. Echinacea products differ in species, plant parts and extraction. [3]
4. Random and blinded? Randomized, placebo-controlled trials are stronger than observational ones. The sleep and cold study measured sleep and then exposed people to virus, but still shows association. [8]
5. How big and how certain? Small studies are preliminary: the elderberry meta-analysis included 180 participants. [9]
6. Who benefits if it works? Check funding and conflicts of interest.
7. Is the result in people? Animal and cell findings are preclinical.

Where to look next

Browse the Research Library, the section pages for herb research and mushroom research, and research and safety sources. For how the immune system works, see how the immune system works.

Gaps we noticed

• We could not read the US CDC vaccine pages in this review, so vaccine content relies on WHO and NHS pages.
• The NHS vitamin and mineral pages we used were last reviewed in 2020.
• For medicinal mushrooms and chicken soup, we found no human trials on colds: proper evidence not found.